Global Monkeypox Treatment Market Size To Worth USD 211 Million By 2033 | CAGR Of 11.20%
Category: HealthcareGlobal Monkeypox Treatment Market Size To Worth USD 211 Million By 2033
According to a research report published by Spherical Insights & Consulting, the Global Monkeypox Treatment Market Size is to Grow from USD 73 Million in 2023 to USD 211 Million by 2033, at a Compound Annual Growth Rate (CAGR) of 11.20% during the projected period.
Get more details on this report -
Browse key industry insights spread across 254 pages with 110 Market data tables and figures & charts from the report on the "Global Monkeypox Treatment Market Size, Share, and COVID-19 Impact Analysis, By Route of Administration (Oral, Injectable, and Topical), By Treatment (Antiviral Medication, Vaccines, Supportive Care, and Immunoglobulins), By End-User (Hospitals and Clinics, Specialty Centers, and Research Institutes), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/monkeypox-treatment-market
Monkeypox is a viral zoonotic disease caused by the monkeypox virus, a member of the Orthopoxvirus genus, similar to the virus that causes smallpox. It is transmitted to humans through close contact with infected animals, humans, or contaminated materials. Symptoms include fever, headache, muscle aches, swollen lymph nodes, and a distinctive rash that progresses to pustules. While less severe than smallpox, monkeypox can lead to complications, particularly in immunocompromised individuals. Treatment primarily involves supportive care to alleviate symptoms, such as pain relief and hydration. Antiviral medications like Tecovirimat (TPOXX) have been approved for severe cases, and vaccines like Jynneos and ACAM2000, originally developed for smallpox, offer effective prevention. Early diagnosis, isolation of infected individuals, and vaccination are key strategies in managing outbreaks and reducing transmission rates. However, a downside of monkeypox treatment is the limited availability and accessibility of antiviral medications and vaccines, particularly in low-income and remote regions.
The injectable segment is anticipated to hold the greatest share of the global monkeypox treatment market during the projected timeframe.
Based on the route of administration, the global monkeypox treatment market is divided into oral, injectable, and topical. Among these, the injectable segment is anticipated to hold the greatest share of the global monkeypox treatment market during the projected timeframe. The injectable monkeypox treatment market is expected to experience significant growth due to the increasing use of injection-based vaccines and antiviral treatments, driven by government campaigns and advancements in delivery technologies.
The antiviral medication segment is anticipated to grow at the fastest pace in the global monkeypox treatment market during the projected timeframe.
Based on the treatment, the global monkeypox treatment market is divided into antiviral medication, vaccines, supportive care, and immunoglobulins. Among these, the antiviral medication segment is anticipated to grow at the fastest pace in the global monkeypox treatment market during the projected timeframe. The antiviral medication segment is expected to grow in the monkeypox treatment market due to increasing use, government approvals, and research into new therapies, highlighting global concern over outbreaks.
The hospital and clinic segment is anticipated to grow at the fastest pace in the global monkeypox treatment market during the projected timeframe.
Based on the end-user, the global monkeypox treatment market is divided into hospitals and clinics, specialty centers, and research institutes. Among these, the hospitals and clinics segment is anticipated to grow at the fastest pace in the global monkeypox treatment market during the projected timeframe. Hospitals and clinics are expected to experience significant growth in the monkeypox treatment market due to increased demand, focus on infectious disease preparedness, and government funding.
North America is expected to hold the largest share of the global monkeypox treatment market over the forecast period.
Get more details on this report -
North America is expected to hold the largest share of the global monkeypox treatment market over the forecast period. The U.S. is expected to dominate the global monkeypox treatment market due to advanced healthcare infrastructure, robust outbreak control initiatives, significant vaccine investments, and public health awareness.
Asia Pacific is predicted to grow at the fastest pace in the global monkeypox treatment market during the projected timeframe. The region’s monkeypox treatment market is expected to grow rapidly in the region due to increased awareness, healthcare expenditures, and the involvement of regional pharmaceutical companies.
Major vendors in the Global Monkeypox Treatment Market include Emergent BioSolutions, Bavarian Nordic, SIGA Technologies, Chimerix, Pfizer Inc., GlaxoSmithKline, Jinan Jinda Pharmaceutical Chemistry Co., Ltd, Gilead Sciences, Merck & Co., Moderna Inc., Sanofi SA, BioNTech, Emcure Pharmaceuticals, Novartis, AstraZeneca, and Others.
Recent Developments
- In August 2022, Oxford University initiated a new clinical trial to evaluate a therapy for monkeypox.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Global Monkeypox Treatment Market based on the below-mentioned segments:
Global Monkeypox Treatment Market, By Route of Administration
- Oral
- Injectable
- Topical
Global Monkeypox Treatment Market, By Treatment
- Antiviral Medication
- Vaccines
- Supportive Care
- Immunoglobulins
Global Monkeypox Treatment Market, By End-User
- Hospitals And Clinics
- Specialty Centers
- Research Institutes
Global Monkeypox Treatment Market, Regional
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- Uk
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?